The FDA approval of Otulfi™, Fresenius Kabi’s fourth biosimilar product in the U.S. market, is an important milestone on our pathway to consistently broadening our biopharma portfolio in the U.S. and ...
In this free webinar, learn about the science behind omega 3, 9 and 11 fatty acids and their impact on metabolic processes and the adipose tissue. Attendees will gain insights into key evidence on the ...
Real-time index price for Nasdaq Biotechnology Index (NBI), along with buy or sell indicators, analysis, charts, historical performance, news and more ...